Focal One® brings the answer to all requirements for ideal focal HIFU ablation: accurate and MR-fused imaging, non-invasive surgical approach, as well as precise and efficient therapeutic energy.
Stereotactic Lithotripsy. "Freeline" ultrasound localization system. A user-friendly system to guarantee the best treatment efficacy. Available on the Sonolith® product range.
EDAP TMS SA, a global leader in robotic energy-based therapies, today announced preliminary unaudited fourth quarter and full year 2022 revenue and other financial highlights.
Read more
EDAP TMS SA, the global leader in robotic energy-based therapies, today announced positive clinical results from the Endo-HIFU-R1 Phase 2 study evaluating the safety of therapeutic high-Intensity focused ultrasound (HIFU) for the treatment of rectal endometriosis. Results from the study were presented by study coordinator, Pr. Gil Dubernard of Croix Rousse University Hospital (Lyon, France), on Friday, January 27, at the Paris Santé Femmes French Congress1 (Lille, France).
Read more
EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Proposed Rule for CY23
Read more
EDAP’s Focal One® HIFU to be Showcased at Two Major Robotics & Urology International Congresses
Read more
Prof. Gil Dubernard, Head of the Gynecology Department at Croix-Rousse University Hospital, Lyon, France, will deliver a presentation at the 6th European Endometriosis Congress
Read more
As a world leader in extracorporeal lithotripsy for more than 30 years, EDAP TMS offers a complete range of non-invasive and minimally invasive solutions covering the full scope of Urinary Tract Stone Indications.
As an alternative to standard radical therapies to treat prostate conditions, EDAP TMS offers a non-invasive solution to ablate prostate tissue based on High Intensity Ultrasound (HIFU)…